Nasdaq

Smith+Nephew's PICO™ 7 and PICO 14 Negative Pressure Wound Therapy Systems are the first systems indicated to aid in reducing the incidence of both deep and superficial ...

Superficial and deep incisional surgical site infections (SSIs) for high risk patients in Class I and Class II wounds Post-operative seroma Dehiscence The development of post-operative surgical site ...
Business Insider

Smith+Nephew comparative study1 shows PICO sNPWT (-80 mmHg) delivers superior performance in relation to wound dehiscence and reduces healthcare costs across cardiovascular and ...

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces findings from a newly published, first-of-its-kind comparative study of single-use negative pressure wound ...
Seeking Alpha

Smith+Nephew’s PICO™ Single Use Negative Pressure Wound Therapy System provides better clinical outcomes versus standard of care according to UK National Institute for ...

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces the review of medical technologies guidance from the UK National Institute for Health and Care Excellence (NICE) ...
WKRN-TV

Smith+Nephew comparative study1 shows PICO sNPWT (-80 mmHg) delivers superior performance in relation to wound dehiscence and reduces healthcare costs across cardiovascular and ...

Smith + Nephew's PICO Single Use Negative Pressure Wound Therapy System An estimated 313 million surgical procedures are performed worldwide each year, with the number continuing to rise. 2 In the ...
abc27

Smith+Nephew comparative study1 shows PICO sNPWT (-80 mmHg) delivers superior performance in relation to wound dehiscence and reduces healthcare costs across cardiovascular and ...

Smith + Nephew's PICO Single Use Negative Pressure Wound Therapy System An estimated 313 million surgical procedures are performed worldwide each year, with the number continuing to rise. 2 In the ...